Skip to main content
Erschienen in: Tumor Biology 2/2016

17.09.2015 | Original Article

Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma

verfasst von: Anna M. Wirsing, Oddveig G. Rikardsen, Sonja E. Steigen, Lars Uhlin-Hansen, Elin Hadler-Olsen

Erschienen in: Tumor Biology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Staging of oral squamous cell carcinoma is based on the tumour-node-metastasis (TNM) system, which has been deemed insufficient for prognostic purposes. Hence, better prognostic tools are needed to reflect the biological diversity of these cancers. Previously, high numbers of specialized blood vessels called high-endothelial venules have been reported to be associated with prolonged survival in patients with breast cancer. In this study, we analysed the prognostic value and morphological characteristics of tumour-associated high-endothelial venules in oral cancer. The presence of tumour-associated high-endothelial venules was evaluated by immunohistochemistry in 75 patients with oral squamous cell carcinoma and analysed with correlation to clinicopathological parameters, patients’ survival and vessel morphology. Ten of the samples were analysed at multiple levels to evaluate intratumoural heterogeneity. The presence of tumour-associated high-endothelial venules was found to be associated with lower disease-specific death in multivariate regression analyses (P = 0.002). High-endothelial venules were present in all (n = 53) T1-T2 tumours, but only in two thirds (n = 14) of the T3-T4 tumours. The morphology of high-endothelial venules was heterogeneous and correlated with lymphocyte density. High-endothelial venules were found to be distributed homogeneously within the tumours. We found the presence of tumour-associated high-endothelial venules to be an easy-to-use, robust, and independent positive prognostic factor for patients with oral cancer. Absence of these vessels in advanced-stage tumours might identify patients with more aggressive disease. Evaluating the presence of tumour-associated high-endothelial venules might help to tailor the treatment of oral cancer patients to their individual needs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.
2.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. New Jersey: John Wiley & Sons; 2011. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. New Jersey: John Wiley & Sons; 2011.
3.
Zurück zum Zitat Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22.CrossRefPubMed Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22.CrossRefPubMed
4.
Zurück zum Zitat Rodrigues P, Miguel M, Bagordakis E, Fonseca F, de Aquino S, Santos-Silva A, et al. Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg. 2014;43(7):795–801.CrossRefPubMed Rodrigues P, Miguel M, Bagordakis E, Fonseca F, de Aquino S, Santos-Silva A, et al. Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg. 2014;43(7):795–801.CrossRefPubMed
5.
Zurück zum Zitat Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck. 2009;31(12):1544–56.CrossRefPubMed Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck. 2009;31(12):1544–56.CrossRefPubMed
6.
Zurück zum Zitat Valenciano A, Henríquez-Hernández L, Lloret M, Pinar B, Lara P. New biological markers in the decision of treatment of head and neck cancer patients. Clin Transl Oncol. 2014;16(10):849–58.CrossRefPubMed Valenciano A, Henríquez-Hernández L, Lloret M, Pinar B, Lara P. New biological markers in the decision of treatment of head and neck cancer patients. Clin Transl Oncol. 2014;16(10):849–58.CrossRefPubMed
7.
Zurück zum Zitat Oliveira L, Ribeiro-Silva A. Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2011;40(3):298–307.CrossRefPubMed Oliveira L, Ribeiro-Silva A. Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2011;40(3):298–307.CrossRefPubMed
8.
Zurück zum Zitat Søland TM, Brusevold IJ. Prognostic molecular markers in cancer–quo vadis? Histopathology. 2013;63(3):297–308.CrossRefPubMed Søland TM, Brusevold IJ. Prognostic molecular markers in cancer–quo vadis? Histopathology. 2013;63(3):297–308.CrossRefPubMed
10.
Zurück zum Zitat Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie J-J, et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 2011;71(17):5678–87.CrossRefPubMed Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie J-J, et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 2011;71(17):5678–87.CrossRefPubMed
11.
Zurück zum Zitat Martinet L, Garrido I, Girard J-P. Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer. OncoImmunology. 2012;1(5):789–90. Martinet L, Garrido I, Girard J-P. Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer. OncoImmunology. 2012;1(5):789–90.
12.
Zurück zum Zitat Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7(4):344–53.CrossRefPubMed Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7(4):344–53.CrossRefPubMed
13.
Zurück zum Zitat Hayasaka H, Taniguchi K, Fukai S, Miyasaka M. Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking. Cancer Sci. 2010;101(11):2302–8.CrossRefPubMed Hayasaka H, Taniguchi K, Fukai S, Miyasaka M. Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking. Cancer Sci. 2010;101(11):2302–8.CrossRefPubMed
14.
Zurück zum Zitat Hwang ST, Singer MS, Giblin PA, Yednock TA, Bacon KB, Simon SI, et al. GlyCAM-1, a physiologic ligand for L-selectin, activates beta 2 integrins on naive peripheral lymphocytes. J Exp Med. 1996;184(4):1343–8.CrossRefPubMed Hwang ST, Singer MS, Giblin PA, Yednock TA, Bacon KB, Simon SI, et al. GlyCAM-1, a physiologic ligand for L-selectin, activates beta 2 integrins on naive peripheral lymphocytes. J Exp Med. 1996;184(4):1343–8.CrossRefPubMed
15.
Zurück zum Zitat Girard J-P, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today. 1995;16(9):449–57.CrossRefPubMed Girard J-P, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today. 1995;16(9):449–57.CrossRefPubMed
16.
Zurück zum Zitat Goc J, Fridman W-H, Sautès-Fridman C, Dieu-Nosjean M-C. Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology. 2013;2(12):e26836. Goc J, Fridman W-H, Sautès-Fridman C, Dieu-Nosjean M-C. Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology. 2013;2(12):e26836.
17.
Zurück zum Zitat Anderson AO, Shaw S. T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Seminars in immunology. San Diego: Academic Press; 1993. p. 271–82. Anderson AO, Shaw S. T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Seminars in immunology. San Diego: Academic Press; 1993. p. 271–82.
18.
Zurück zum Zitat Pagès F, Galon J, Dieu-Nosjean M-C, Tartour E, Sautès-Fridman C, Fridman W-H. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010;29(8):1093–102. Pagès F, Galon J, Dieu-Nosjean M-C, Tartour E, Sautès-Fridman C, Fridman W-H. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010;29(8):1093–102.
19.
Zurück zum Zitat Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306.CrossRefPubMed Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306.CrossRefPubMed
20.
21.
Zurück zum Zitat Dieu-Nosjean M-C, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008;26(27):4410–7.CrossRefPubMed Dieu-Nosjean M-C, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008;26(27):4410–7.CrossRefPubMed
22.
Zurück zum Zitat Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol. 2011;179(1):37–45.CrossRefPubMedPubMedCentral Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol. 2011;179(1):37–45.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Wirsing AM, Rikardsen OG, Steigen SE, Uhlin-Hansen L, Hadler-Olsen E. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma. BMC Clin Pathol. 2014;14(1):38.CrossRefPubMedPubMedCentral Wirsing AM, Rikardsen OG, Steigen SE, Uhlin-Hansen L, Hadler-Olsen E. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma. BMC Clin Pathol. 2014;14(1):38.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Veerman KM, Lafouresse F, Girard J-P. Tumor high endothelial venules and lymphocyte trafficking. Molecular Mechanisms of Angiogenesis. Paris: Springer; 2014. p. 339–52 Veerman KM, Lafouresse F, Girard J-P. Tumor high endothelial venules and lymphocyte trafficking. Molecular Mechanisms of Angiogenesis. Paris: Springer; 2014. p. 339–52
25.
Zurück zum Zitat Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol. 2006;177(5):3369–79.CrossRefPubMed Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol. 2006;177(5):3369–79.CrossRefPubMed
26.
Zurück zum Zitat Moussion C, Girard J-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature. 2011;479(7374):542–6.CrossRefPubMed Moussion C, Girard J-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature. 2011;479(7374):542–6.CrossRefPubMed
27.
Zurück zum Zitat Lee SY, Qian C-N, Ooi AS, Chen P, Wong HMB, Myint SS, et al. Changes in specialized blood vessels in lymph nodes and their role in cancer metastasis. J Transl Med. 2012;10(1):206.CrossRefPubMedPubMedCentral Lee SY, Qian C-N, Ooi AS, Chen P, Wong HMB, Myint SS, et al. Changes in specialized blood vessels in lymph nodes and their role in cancer metastasis. J Transl Med. 2012;10(1):206.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Qian C-N, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, et al. Preparing the “soil”: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 2006;66(21):10365–76.CrossRefPubMed Qian C-N, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, et al. Preparing the “soil”: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 2006;66(21):10365–76.CrossRefPubMed
29.
Zurück zum Zitat Rosen SD, Daneman R. High endothelial venules through a transcriptomics lens. Nat Immunol. 2014;15(10):906–8.CrossRefPubMed Rosen SD, Daneman R. High endothelial venules through a transcriptomics lens. Nat Immunol. 2014;15(10):906–8.CrossRefPubMed
30.
Zurück zum Zitat Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med. 2012;10(1):51.CrossRefPubMedPubMedCentral Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med. 2012;10(1):51.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Beahrs OH, Myers MH. Manual for staging of cancer. 2nd ed. Philadelphia: J.B. Lippincott; 1983. p. 27–32. Beahrs OH, Myers MH. Manual for staging of cancer. 2nd ed. Philadelphia: J.B. Lippincott; 1983. p. 27–32.
32.
Zurück zum Zitat Beahrs OH, Henson DE, Hutter RVP, Myers MH. Manual for staging of cancer. 3rd ed. Philadelphia: J.B. Lippincott; 1988. p. 27–32. Beahrs OH, Henson DE, Hutter RVP, Myers MH. Manual for staging of cancer. 3rd ed. Philadelphia: J.B. Lippincott; 1988. p. 27–32.
33.
Zurück zum Zitat Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. 4th ed. Philadelphia: J.B. Lippincott; 1992. p. 25–30. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. 4th ed. Philadelphia: J.B. Lippincott; 1992. p. 25–30.
34.
Zurück zum Zitat Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC Cancer staging manual. 5th ed. Philadelphia, New York: Lippincott-Raven; 1997. p. 24–30. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC Cancer staging manual. 5th ed. Philadelphia, New York: Lippincott-Raven; 1997. p. 24–30.
35.
Zurück zum Zitat Hadler-Olsen E, Wetting HL, Rikardsen O, Steigen SE, Kanapathippillai P, Grénman R, et al. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchows Arch. 2010;457(6):677–92.CrossRefPubMedPubMedCentral Hadler-Olsen E, Wetting HL, Rikardsen O, Steigen SE, Kanapathippillai P, Grénman R, et al. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchows Arch. 2010;457(6):677–92.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Weidner N, Carroll P, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143(2):401.PubMedPubMedCentral Weidner N, Carroll P, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143(2):401.PubMedPubMedCentral
37.
Zurück zum Zitat Ghaznavi F, Evans A, Madabhushi A, Feldman M. Digital imaging in pathology: whole-slide imaging and beyond. Annu Rev Pathol: Mech Dis. 2013;8:331–59.CrossRef Ghaznavi F, Evans A, Madabhushi A, Feldman M. Digital imaging in pathology: whole-slide imaging and beyond. Annu Rev Pathol: Mech Dis. 2013;8:331–59.CrossRef
38.
Zurück zum Zitat Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P, et al. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. OncoImmunology. 2012;1(6):829–39.CrossRefPubMedPubMedCentral Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P, et al. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. OncoImmunology. 2012;1(6):829–39.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Avram G, Sánchez‐Sendra B, Martín JM, Terrádez L, Ramos D, Monteagudo C. The density and type of MECA‐79‐positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma. Histopathology. 2013;63(6):852–61.CrossRefPubMed Avram G, Sánchez‐Sendra B, Martín JM, Terrádez L, Ramos D, Monteagudo C. The density and type of MECA‐79‐positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma. Histopathology. 2013;63(6):852–61.CrossRefPubMed
40.
Zurück zum Zitat de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res. 2011;71(20):6391–9.CrossRefPubMed de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res. 2011;71(20):6391–9.CrossRefPubMed
41.
Zurück zum Zitat Seoane J, Mattos‐Arruda D. The challenge of intratumour heterogeneity in precision medicine. J Intern Med. 2014;276(1):41–51.CrossRefPubMed Seoane J, Mattos‐Arruda D. The challenge of intratumour heterogeneity in precision medicine. J Intern Med. 2014;276(1):41–51.CrossRefPubMed
42.
Zurück zum Zitat Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard J-P. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer. J Immunol. 2013;191(4):2001–8.CrossRefPubMed Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard J-P. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer. J Immunol. 2013;191(4):2001–8.CrossRefPubMed
Metadaten
Titel
Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma
verfasst von
Anna M. Wirsing
Oddveig G. Rikardsen
Sonja E. Steigen
Lars Uhlin-Hansen
Elin Hadler-Olsen
Publikationsdatum
17.09.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 2/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4036-4

Weitere Artikel der Ausgabe 2/2016

Tumor Biology 2/2016 Zur Ausgabe

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.